نتایج جستجو برای: vkorc1

تعداد نتایج: 527  

Journal: :Pharmacogenetics and Genomics 2010

2008
M. Teichert L. E. Visser R.H.N. van Schaik A. Hofman A. G. Uitterlinden

Objective—Besides effects on hemostasis, vitamin K-dependent proteins play a role in bone mineralization and arterial calcification. We investigated the association between the VKORC1 1173C T polymorphism and calcification of the aortic far wall in a large population-based cohort. Methods and Results—Aortic calcification was diagnosed by radiographic detection of calcified deposits in the abdom...

2016
Silvia Misasi Giuliana Martini Oriana Paoletti Stefano Calza Giovanni Scovoli Alessandra Marengoni Sophie Testa Luigi Caimi Eleonora Marchina

Vitamin K antagonists (VKAs) are highly effective but have a narrow therapeutic index and require routine monitoring of the INR. The primary aim of pharmacogenetics (PGx) is to optimize patient care, achieving drug treatments that are personalized according to the genetic profile of each patient. The best-characterized genes involved in VKA PGx involve pharmacokinetics (VKORC1) and pharmacodyna...

2017
J. Oldenburg H. Seidel B. Pötzsch M. Watzka

Zusammenfassung Die Identifizierung der Vitamin-K-Epoxid-Reduktase (VKORC1) hat maßgeblich zu einem besseren Verständnis des Vitamin-K-Zyklus beigetragen. Das VKORC1-Protein konnte als das molekulare Target der Cumarine charakterisiert werden und stellt das geschwindigkeitsbestimmende Enzym des Vitamin-K-Zyklus und möglicherweise die alleinige Komponente der VKOR-Aktivität dar. Mutationen und P...

Journal: :Clinical pharmacology and therapeutics 2017
J A Johnson K E Caudle L Gong M Whirl-Carrillo C M Stein S A Scott M T Lee B F Gage S E Kimmel M A Perera J L Anderson M Pirmohamed T E Klein N A Limdi L H Cavallari M Wadelius

This document is an update to the 2011 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and VKORC1 genotypes and warfarin dosing. Evidence from the published literature is presented for CYP2C9, VKORC1, CYP4F2, and rs12777823 genotype-guided warfarin dosing to achieve a target international normalized ratio of 2-3 when clinical genotype results are available. In ad...

Warfarin is a vitamin K antagonist that genetic and non-genetic factors affected on its doserequirement in the patients with cardio vascular disease. The aim of this study was whetherthe APOE and VKORC1 polymorphisms influence on warfarin dose requirements in the partof Iranian patients. Blood samples were collected from 86 warfarin-treated patients. Afterextraction of genomic DNA, the VKORC1 (...

2015
Mathieu Ferron Julie Lacombe Amélie Germain Franck Oury Gérard Karsenty

Osteocalcin (OCN) is an osteoblast-derived hormone favoring glucose homeostasis, energy expenditure, male fertility, brain development, and cognition. Before being secreted by osteoblasts in the bone extracellular matrix, OCN is γ-carboxylated by the γ-carboxylase (GGCX) on three glutamic acid residues, a cellular process requiring reduction of vitamin K (VK) by a second enzyme, a reductase cal...

2014
Jinxing Chen Liying Shao Ling Gong Fang Luo Jin'e Wang Yi Shi Yu Tan Qianlong Chen Yu Zhang Rutai Hui Yibo Wang

Inconsistent associations with warfarin dose were observed in genetic variants except VKORC1 haplotype and CYP2C9*3 in Chinese people, and few studies on warfarin dose algorithm was performed in a large Chinese Han population lived in Northern China. Of 787 consenting patients with heart-valve replacements who were receiving long-term warfarin maintenance therapy, 20 related Single nucleotide p...

2016
Filipp Filippovich Vasilyev Diana Aleksandrovna Danilova Vladimir Sergeevich Kaimonov Yana Valerievna Chertovskih Nadezda Romanovna Maksimova

Allele frequencies of single nucleotide polymorphisms (SNPs) are variable among different populations; therefore the study of SNPs in ethnic groups is important for establishing the clinical significance of the screening of these polymorphisms. The main goal of the research is to study the polymorphisms of CYP2C9, CYP2C19, VKORC1, and SLCO1B1 in Yakuts. Genomic DNA from 229 Yakut subjects were ...

2017
Sajad Rafiee Masoumeh Rajabibazl Reza Meshkani Azam Daraei Mehryar Zargari Fahimeh Sharafeddin Zahra Fazeli Attabak Toffani Milani Maryam Taherkhani

Warfarin is a vitamin K antagonist that genetic and non-genetic factors affected on its dose requirement in the patients with cardio vascular disease. The aim of this study was whether the APOE and VKORC1 polymorphisms influence on warfarin dose requirements in the part of Iranian patients. Blood samples were collected from 86 warfarin-treated patients. After extraction of genomic DNA, the VKOR...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید